Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Gene therapy is certainly one area to watch going forward, Hurst.
The investors in the last Affyxell funding round were:
Avacta Group
Shinhan Venture
Kolon Venture
Samsung Venture
Stonebridge Ventures
Gyeongnam Venture
Smilegate Inv
I see that Stonebridge set milestone targets for putting in further investment:
https://www.stonebridge.co.kr/venture-capital
Doesn't look like there would be a shortage of suitors for an IPO.
Onwards Avacta Group.
Enjoy your tea, DTW.
Your analogy with Wembley and football tickets is ludicrous (sorry) as it ignores all other football games just as your elastic argument ignores all other shares.
As I said earlier, not worth debating but if you do then please don't post diatribe.
All the best.
DTW,
If you think that 263 million is "perfectly inelastic" then I happily give up.
I won't bother with "no alternative" as there are obviously no other shares in any other companies
available for people to buy.
All the best.
I'll try, DTW.
'If supply remains constant and demand increases, prices will rise' - we know supply is inelastic, i.e. there are only a finite number of shares available, hence as more people seek to BUY shares then demand increases and the price rises."
So when supply doesn't remain constant (and increases) what happens?
I think Adam Smith covered this by using the word "constant".
Hence I will stick with buyers do force the price down when there are willing sellers and force the price up when there aren't many sellers. They force the price way up when there are no sellers.
I accept that Wyndrum may not have explained it this way exactly but the number/volume of sellers is key to what Adam Smith said.
Probably a waste of time discussing this here do you think?
All the best.
If you type Avacta Group subsidiaries into Google you get a list which I have not heard of before (apart from Animal Health which is now sold).
Can anyone enlighten me on what this means if anything?
Cheers.
... I think this is the bit a lot of people are missing:
"Avacta is now a Distributor and can sell their Affimers via their new purchase. The new company already brings £9m profit to our bottom line."
Onwards Avacta Group.